News Hub | News Direct

Quantitative Easing Could Occur Soon – Here's What That Could Mean For Crypto, And How To Benefit

Benzinga

By Kyle Anthony, Benzinga The global macroeconomic landscape is changing, as the Bank of Canada (BoC) and European Central Bank (ECB) recently cut interest rates in their respective economies due to declining inflation and encouraging economic readings in recent months. The reduction of interest rates by both the BoC and ECB raises expectations of interest rate cuts by the Federal Reserve (Fed) in the near future. For many cryptocurrency investors, such an action would positively impact their cryptocurrency investments and open up the opportunity to achieve additional liquidity. The Macroeconomic Backdrop The Federal Reserve adjusts the federal funds target rate range in response to what’s happening in the economy. Adjusting rates helps the Fed achieve conditions that satisfy their dual mandate: keeping prices stable and maximizing employment. While the considerations and variables that underpin the monetary policy actions of the Fed are numerous, in simplified terms, the Fed raises interest rates when the economy starts overheating (i.e. elevated inflation) and cuts rates when the economy looks weak (i.e. high unemployment). Against the backdrop of elevated inflation stemming from the COVID-19 pandemic, the Federal Reserve raised rates 11 times between March 17, 2022 and July 27, 2023. In subsequent meetings about the federal funds target rate, the Fed maintained the current rate level of 5.25% to 5.50%. With U.S. inflation significantly down from historical highs and the actions of other central banks being a motivating factor, the desire for quantitative easing – the reduction of interest rates and increase in the money supply through the purchase of securities by the central bank – is growing among investors and individuals alike. Interest Rate Change Impact on Cryptocurrency Cryptocurrencies, like any risk asset such as equities or fixed income, are impacted by interest rates. A lower interest rate stimulates the economy, encouraging consumer spending and investment, increasing borrowing and buoying economic activity. Thus, it can be a boon for asset acquisition, driving prices up. It is also worth noting that lower rates disincentivize individuals from saving their money via certificates of deposits and other term-to-maturity instruments, instead compelling many to seek out riskier assets like crypto to pursue higher returns. This increased demand can drive up crypto prices. The relationship between interest rates and cryptocurrencies can be gleaned from the historical price of Bitcoin. During the era of extremely low interest rates, Bitcoin’s price reached then record highs, surpassing the $60,000 price threshold. However, a material drawdown, approximately 70%, occurred once the Fed began raising rates to combat rising inflation. Though Bitcoin’s price has recovered, this was due to events such as its halving and the SEC’s approval of spot Bitcoin ETFs. Once a macroeconomic change – such as the reduction of interest rates – occurs, the price of Bitcoin and other cryptocurrency assets may be pushed upward. The chart below highlights the inverse relationship between the federal funds effective rate and the price of Bitcoin. Gaining Exposure To Crypto With Professional Guidance For investors who desire direct cryptocurrency ownership, Caleb & Brown, the crypto investor’s expert partner, provides personalized service for beginners and advanced investors alike. The company makes Bitcoin and hundreds of other crypto assets readily available for one’s portfolio. With 24/7 access to a personal relationship manager, investors can buy crypto with fiat currency and no deposit fees. Since Caleb & Brown doesn’t need to deal with network latency issues which sometimes plague exchanges, clients will have access to a pool of interchangeable assets. This not only makes crypto acquisition easier, but it also makes other difficult-to-access tokens easier to acquire. With over 20,000 crypto assets in existence, each with its own uses and applications, Caleb & Brown can provide its customers with resources and insights on the cryptocurrency landscape that can aid them in their decision-making and give them the confidence needed to navigate the world of crypto. Embark on your cryptocurrency investing journey with Caleb & Brown here. Featured photo by André François McKenzie on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

July 30, 2024 08:50 AM Eastern Daylight Time

Image

News Release

KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment

RazorPitch KDLY

Amidst the ongoing opioid crisis, which has prompted increasing scrutiny of traditional pain treatments, there is a growing recognition of the need for comprehensive and effective approaches to pain relief. This shift is creating a market for innovative solutions that integrate conventional medical practices with alternative therapies, such as medical cannabis. As more patients and providers seek to navigate the complexities of pain management, the landscape is evolving rapidly, paving the way for new opportunities in healthcare delivery. KindlyMD, Inc. (NASDAQ: KDLY) has emerged as a pioneer in integrating traditional primary care with alternative pain management strategies. Founded on a patient-first philosophy, KindlyMD operates four centers, including the largest alternative pain treatment center in Utah. The company combines primary care, pain management, behavioral therapy, and alternative treatments, including medical cannabis recommendations, to offer comprehensive care and reduce opioid dependency. Financial Milestones and Market Presence KDLY announced the closing of its IPO of 1,240,910 units at $5.50 per unit, raising approximately $6.8 million in gross proceeds back in early June. This financial boost positions KindlyMD to execute its growth strategy effectively. Additionally, KindlyMD has made significant strides in becoming the first alternative medical treatment company in Utah to contract with the state's top insurance payors, including Select Health, Medicare, Medicaid, and Blue Cross Blue Shield, covering nearly 80% of Utah's population. "This is a major milestone for KindlyMD," said Tim Pickett, PA-C, founder and CEO of KindlyMD. "Now, the scope of services we provide at our Company-branded clinics, including behavioral healthcare and medical interventions incorporating alternative medicine, are covered by and reimbursable by the largest insurance providers across the state." Addressing the Opioid Crisis Provisional data from the CDC's National Center for Health Statistics indicates that in 2021, nearly 108,000 people died of drug overdose in the U.S., with over 80,000 of these deaths attributed to opioids. The government has responded with the largest opioid treatment grant funding ever. Despite widespread use of prescription medication among Americans aged 45-64, many of these prescriptions are insufficient and carry significant long-term side effects. KindlyMD is addressing this crisis head-on by offering non-opioid treatment options like medical cannabis, which have become more widespread in recent years. However, these options are often excluded from clinical recommendations and guidelines, creating an unmet need that KindlyMD aims to fill. To date, the company has seen over 60,000 patient visits in its clinics, providing comprehensive care plans that ensure safe use, appropriate dosing, and behavioral health support for those who need opioids. Strategic Collaborations and Community Outreach On June 10, KDLY announced a collaboration with Curaleaf Holdings, Inc., a leading international provider of cannabis products. The two companies are working together to provide educational resources on holistic pain management and treatment options, including medical cannabis. This partnership includes community care events throughout the summer, aiming to enhance patients understanding of holistic pain management "Our innovative collaboration with Curaleaf will provide more patients with access to pain management treatment options and alternative therapies," said Tim Pickett. "As the U.S. government moves toward rescheduling cannabis as a legitimate medicine, this collaboration will help more patients find sustainable, safer, and more affordable healthcare treatment options." KDLY recently submitted a comment to the U.S. Department of Justice regarding the proposed reclassification of cannabis from Schedule I to Schedule III of the Controlled Substances Act. This reclassification is expected to have several positive impacts on the medical cannabis industry, including reducing patient costs and enabling businesses to deduct standard operating expenses. "Reclassification underscores the continued relevance and importance of our integrated healthcare model," said Tim Pickett. "It will likely lead to increased access and utilization of medical cannabis among our patients, benefiting KindlyMD through improved patient outcomes, new educational opportunities, and enhanced financial stability." Federal Funding Initiatives KindlyMD's successful registration on SAM.gov, the official U.S. federal funding platform, marks a significant milestone for the company. This registration enables KindlyMD to obtain federal grants and contracts, including those with the Department of Veterans Affairs, to support its mission of providing comprehensive healthcare solutions. Following its registration, KindlyMD submitted its first grant application for the USDA Rural Utilities Service Distance Learning and Telemedicine Grant Program, seeking $1,000,000 to expand its Complete Care telehealth program in rural communities in Utah. This program aims to deliver effective healthcare through an interconnected network of telemedicine clinics, addressing the unique challenges faced by rural populations. Financial Performance For the quarter ended March 31, 2024, KDLY reported revenues of $829,029, a decrease compared to the previous year, primarily due to a shift towards insurance billing. However, the company began receiving reimbursements from insurance payors for the first time in its history during this period, amounting to $34,722. Operating expenses decreased by 21.9%, and the company reported a net loss per share decrease of 50%. The capital raised from the IPO will enable KindlyMD to invest in growth opportunities, including mergers and acquisitions of additional clinics in Utah. With over 16% of the medical cannabis patient population in Utah already under its care, KindlyMD is well-positioned to expand its reach and enhance patient outcomes. KindlyMD, Inc.'s (NASDAQ: KDLY) innovative approach and industry expertise position it uniquely to continue providing unique healthcare services. As the regulatory landscape evolves, KDLY remains a crucial partner for patients seeking alternative and integrative healthcare solutions, particularly in the ongoing battle against the opioid epidemic. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cambridge Consulting to assist in the production and distribution of this content. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details RazorPitch Mark McKelvie +1 585-301-7700

July 29, 2024 06:00 AM Eastern Daylight Time

Playing Your Hand Wisely: Navigating Futures Trading With Precision And Planning

EdgeClear

By Gerelyn Terzo, Benzinga As an online trader, you’re no stranger to playing on probabilities. However, for some, all logic can often disappear when it comes to strategy. For example, you wouldn’t want to enter a high-stakes poker game with a $200 minimum buy-in with only $200 in your pocket; still, some do it. By doing this, you are effectively leaving your fate to chance like a coin flip, and chances are good that after the first hand, you’ll be folding and sacrificing future opportunities early. When trading futures, you wouldn’t want to enter the market without a well-conceived trading plan in place. Formulating a trading plan requires patience and diligence and is essential to success. Otherwise, you could be out of luck and money before you know it. If you’re looking to further inform yourself and improve your trading plans, EdgeClear is an independent futures broker with a wealth of resources for online traders to begin strategizing today. Below, we share some insights from the firm’s educational materials. Steps To Building A Trading Plan A key to building a successful online trading plan is developing your own plan beyond copy trading. If you simply adopt someone else’s strategy without any original research, you could set yourself up for failure by adhering to their risk/reward profile instead of your own. Therefore, the first step to building a trading plan is understanding that your plan should be unique, reflecting your personal goals, style and risk tolerance. Think of your trading plan as your blueprint for investing in the markets. It’s important to refer to your trading blueprint continually to navigate the markets. Your trading plan should remind you daily to stay disciplined, neither veering from your predetermined risk management tactics nor letting your emotions influence your decisions. Remaining consistent and objective is important. At the same time, once you’ve built your trading plan, it’s vital to remain flexible. No matter how comprehensive your blueprint is, it shouldn’t necessarily be set in stone. Instead, it will need to be updated occasionally as you grow as a trader and market conditions pivot. For example, during the COVID era, assets that were normally uncorrelated — like gold and equities — began trading in lockstep with one another. Traders who refused to adapt and make changes would soon realize they were outplayed. Below are four questions that EdgeClear believes every trader should ask themselves when formulating a trading plan. What is your timeframe? First and foremost, you need to ask yourself how long you will test a plan before deciding whether to fully commit to it or abandon ship. Setting a timeframe will give you a point of reference, ensuring that you’re sufficiently prepared with funding and risk management along the way. Allow yourself a specified period to either improve your results or scuttle the plan. Which performance benchmarks are you targeting? It’s also necessary to identify performance metrics, including goals that will continue to challenge you but that are not so lofty that they are unattainable. Without milestones, you wouldn’t know when to celebrate or step it up. As a trader, you can use these benchmarks to keep you motivated and accountable and to wake up the next day and do it all over again even in the face of challenges. For example, you could strive for consistency by trading at least a couple of contracts with a positive risk/reward ratio. Another idea highlighted by EdgeClear is to target a 10% monthly return that you can then scale higher over time. How do you plan to gauge your performance? When you’re assessing your performance as a futures trader, you might be tempted to compare yourself with another trader. More often than not, nothing good comes from that, as the other trader is bringing a different set of skills, a different risk/reward profile and different resources to the fray. Instead, try measuring your performance against your own set of standards while consistently evaluating your results for improvements in areas like profits and losses, understanding that change might not happen overnight. As you adjust your risk/reward profile, target more successful trades — all the while acknowledging your comfort level and level of stress. How can you scale up the amount you’re trading? Once you start to experience success with your trading plan, it’s normal to consider scaling up to bolster your profits. Before you do, make sure you’re ready because while placing bigger bets could lead to greater rewards, it could also amplify losses. EdgeClear recommends considering practical factors like your personal resources while evaluating your past performance against your goals. Even if you are equipped to raise the stakes, make sure that the trade is worthy of a bigger commitment. Measure features like an asset’s liquidity to ensure you don’t unintentionally penalize yourself with things like slippage. Funding And Margin Are Key The CME has a minimum threshold for trading futures contracts. Keep in mind that futures contracts are inherently leveraged. Your broker might provide some day margin, allowing you to enter into a position with lower funds. Treat the day margin as greater buying power, like receiving additional chips at the poker table. However, EdgeClear warns that this margin could also translate into greater losses. If you are day trading with margins less than the required initial margin, positions may not be carried overnight. It's crucial to understand this limitation to avoid unexpected position liquidations. When it comes to funding your account, limit it to the amount of capital you can afford to lose. Avoid using capital that you need for your basic daily needs to fund your account. Otherwise, you are also more likely to increase your stress level. It’s better to reduce your position than trading with volatile emotions. Next, target funding your available risk capital with 100% of the initial margin for each contract you’re trading. For example, let’s say your trading strategy involves up to three E-mini S&P 500 futures, which carry an initial margin of $12,980 per contract (as of 6/17/2024). In this scenario, EdgeClear suggests funding with roughly $40,000, or at least half of that amount, if planning to exclusively day trade. Otherwise, consider downsizing to trading micro contracts. Risk Management And Accountability Go Hand In Hand Risk management is a critical part of any trader’s strategy, whether it’s someone at a trading firm or a retail trader. But in order to have proper risk management, a trader first must establish a partnership with a trusted party like EdgeClear to ensure greater accountability. This partner must be in the loop on your trading plan so that they can provide the support you need to stay on track every day. No matter how hard you work to perfect your trading plan, it’s important to put it to the test every day. Without accountability, it’s simple to become complacent or rest on your laurels, causing you to lose your hard-earned edge. The EdgeClear team boasts several decades of brokerage industry experience and recognizes the importance of providing support to online traders when they have questions — or are looking to take their trading game to the next level. Featured photo by Michał Parzuchowski on Unsplash. A forward-thinking futures broker. Led by industry experts who understand the complexities of trading, Edge Clear combines the best of technology, service and risk control. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Derivatives trading involves a substantial risk of loss and is not suitable for all investors. Contact Details Max Timmins max@edgeclear.com

July 25, 2024 08:35 AM Eastern Daylight Time

Image

BDA Announces 2025 Bermuda Risk Summit Dates

Bermuda Business Development Agency

Hamilton, Bermuda, July 19 th 2024: The Bermuda Risk Summit is set to take place from March 10-12, 2025, at the Hamilton Princess & Beach Club. This premier event promises to bring together industry leaders and experts for three days of insightful discussions and networking opportunities. Kendaree Burgess, COO of the Bermuda Business Development Agency, remarked, " The 2025 Bermuda Risk Summit is a must attend event for Bermuda’s Risk sector, bringing together industry thought leadership, innovation and interest from those seeking to make Bermuda their domicile of choice. This event highlights Bermuda's leadership in risk management and offers a unique platform for industry experts to network and collaborate.” The 2024 Bermuda Risk Summit saw over 450 attendees, with 40% traveling from 30 different countries. The summit featured 50 industry-leading speakers, addressing crucial topics that shape the risk management landscape. Sponsorship Opportunities Sponsorship opportunities for the Bermuda Risk Summit 2025 are now available! Sponsors will have the chance to gain significant visibility and connect with influential leaders in the risk management sector. If you are interested in sponsorship, click here or email bermudarisk@bda.bm. Early Bird Registration and Accommodation Members of the public are encouraged to register early. An early bird rate of $395 will be available until September 30. To avoid disappointment, click here to reserve your hotel room online or call 1-441-295-3000, or the Global Reservations Centre at 1-800-441-1414, using the booking code: ‘Bermuda Risk Summit’ to take advantage of our preferred rate. For more information, please visit our website or contact us at bermudarisk@bda.bm. BERMUDA BUSINESS DEVELOPMENT AGENCY BDA.BM +1 441 292 0632 CONNECTING BUSINESS The BDA encourages direct investment and helps companies start up, re-locate, or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. The Bermuda Business Development Agency (BDA) encourages direct investment and helps companies start up, re-locate, or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Contact Details Bermuda’s Business Development Agency (BDA) Melvin Dickinson +1 441-707-0038 info@bda.bm Company Website https://bda.bm

July 19, 2024 01:56 PM Eastern Daylight Time

Perú introdujo diez nuevas rutas para acceder al Santuario Histórico de Machupicchu

Promperu

Perú introdujo diez nuevas rutas para acceder al Santuario Histórico de Machupicchu durante la temporada alta, del 1 de junio al 15 de octubre de 2024 y del 30 al 31 de diciembre de 2024. Además, dentro de este periodo se superará la capacidad máxima de visitantes a esta maravilla del mundo. ampliado a 5600 por día. Las rutas se articulan y programan con aforos y turnos establecidos con el fin de preservar el patrimonio arqueológico y garantizar una experiencia óptima al visitante. Perú ha desarrollado iniciativas para asegurar la sostenibilidad a largo plazo de su sector turístico. El compromiso del país con prácticas turísticas sostenibles protege sus destinos emblemáticos. Por ejemplo, Machu Picchu es el primer destino turístico en lograr la certificación internacional de carbono neutral. PROMPERÚ pone a disposición el número de WhatsApp (+51 944-492-314) de IPERÚ, miembro de la Red de Protección al Turista, disponible las 24 horas del día de lunes a domingo. Los viajeros pueden comunicarse con este número para recibir información y asistencia. El servicio IPERÚ, prestado por el gobierno de forma gratuita, ofrece a los turistas información oficial y actualizada sobre el país. Una infografía detallada con los atractivos de Machupicchu que se incluyen en cada ruta se puede descargar aquí. Comisión de Promoción del Perú para las Exportaciones y el Turismo (PROMPERÚ). Somos la agencia gubernamental encargada del desarrollo e implementación de estrategias globales para posicionar al Perú a través de la promoción de su imagen, destinos turísticos, exportaciones de valor agregado e inversiones. Contact Details José Carlos Collazo jcollazos@promperu.gob.pe Company Website https://www.promperu.gob.pe

July 18, 2024 03:00 PM Eastern Daylight Time

Image

Forum Health Breaks into Denver Market with Acquisition of Concierge Functional and Regenerative Medicine Practice

Forum Health

Forum Health, LLC, a nationwide network of integrative and functional medicine providers and a pioneer in personalized healthcare, is expanding into a leading wellness-focused city with its acquisition of RevolutionaryMD in Denver, CO. Learn more about RevolutionaryMD. Renowned for its proclivity for health and wellness and prestigious medical research institutions, Denver is the ideal setting for a clinic rooted in personalized, cutting-edge healthcare. Phil Hagerman, Forum Health CEO: “Dr. Grover’s development of his revolutionary functional, regenerative, and anti-aging medical center aligns perfectly with the Forum Health clinic model, making this expansion a natural fit. His thirty years of success and expertise in central Denver is invaluable as we expand to a new state, enhancing the practice’s availability and offerings for wellness-focused patients.” The founder of RevolutionaryMD center in Cherry Creek North, Fred Grover, Jr., MD, is a Board-Certified Family Physician with training and certifications in Integrative, Functional, and Anti-Aging Medicine. He brings a wealth of experience and expertise to Forum Health's expanding network. Fred Grover Jr., MD, RevolutionaryMD Founder: “I’m excited to join Forum Health and grow our services and availability to help patients find a proactive approach to healthcare. We embrace the future of medicine by offering a robust preventative care model to treat the root cause of chronic conditions.” In addition to traditional testing, RevolutionaryMD offers genomic panels, advanced cardiovascular and cancer screening, inflammatory, and nutritional testing. It also employs AI for precise, personalized recommendations, moving beyond the depersonalized, often suboptimal outcomes of standard allopathic medicine. RevolutionaryMD has pioneered the concierge approach of functional medicine, advancing personalized healthcare with the latest treatments in: Anti-Aging and Regenerative Medicine for Improved Healthspan and Lifespan Bioidentical Hormone Replacement Therapy and Restoration Sexual Health and Wellness Aesthetic Dermatology Mind and Body Balancing Through Brain Health Modalities Integrated Ketamine and Sound Therapy for Depression IV Therapy for Post-COVID Syndrome, Inflammation and Healthy Mitochondrial Function Dr. Grover's dedication to functional and integrative medicine is evident in his role as an assistant clinical professor at the University of Colorado, Denver, his Board Certifications in Anti-Aging and Integrative Holistic Medicine, and his authorship of "Spiritual Genomics" and "Awakening Gaia." About Forum Health, LLC Forum Health, LLC is a nationwide provider of personalized healthcare steeped in the powerful principles of functional and integrative medicine. Our providers take a root-cause approach to care exploring lifestyle, environment, and genetics to help each patient achieve their ultimate health goals. Members have access to advanced medical treatments and technology, with care plans informed by data analytics and collaborative relationships. For more, visit www.forumhealth.com. Contact Details Britt Wittelsberger +1 410-852-0738 bwittelsberger@forumhealth.com Company Website https://forumhealth.com

July 18, 2024 08:50 AM Eastern Daylight Time

Image

Total Liquidity Pledge to HTX DAO Hits $42.5M After 2nd Round - Bolstering Decentralized Ecosystem

HTX DAO

HTX DAO has announced its receipt of the second Ecosystem Liquidity Pledge took place on July 16, 2024. Through this pledge, 80,223,880 TRX and 9,631,105,301,954.7 $HTX (worth 21,500,000 USDT) have been allocated to SUN.io to enhance liquidity and all LP tokens have been credited to a zero address. As of press, HTX DAO has reportedly received a total liquidity pledge of $42.5 million. The pledge details can be viewed based on the following transaction hash via TRONSCAN, the TRON blockchain explorer. (The amount of $HTX tokens contributed to liquidity is calculated based on the real-time price of $HTX.) 1. Adding Liquidity Hash: acd664c12d9c32e50dce2fd1c9efea4a6b19793949c515ed49ac06cb620e1331 2. LP Tokens Sent to Zero Address Hash: 4a3912ed71f10ca59fbcc2fd61378a4cc54171f78e10f4b091cb0c5aeedfb44e Learn more about the pledge: https://htxdao-1.gitbook.io/announcement-en According to HTX DAO, the Ecosystem Liquidity Pledge mechanism is an innovation crafted to build a decentralized community empowering the ecosystem and address security-related concerns and allegations of centralization. This carefully structured mechanism not only bolsters the resilience and self-sufficiency of the HTX DAO ecosystem but also ensures transparency and accountability in all its operations. As per the previous report, HTX DAO received the initial liquidity pledge on March 15, totaling $21 million. Additionally, the next pledge is slated for October 15, 2024. HTX DAO's liquidity pledge boasts several sources including a portion of the quarterly revenue from HTX (currently 50%) and contributions from other key HTX DAO participants. This pooled pledge is used to add liquidity for the $HTX token on decentralized exchanges, with the resulting LP tokens being permanently burned. It is noteworthy that any HTX DAO participant has the opportunity to voluntarily donate liquidity to $HTX or TRX. This safeguard improves the practicality and decentralization of asset management and ensures that no single pledger within the HTX DAO can exercise exclusive control over the treasury. A proactive approach is taken to manage liquidity in a decentralized fashion, which systematically addresses the matter of centralization in fund custodianship while simultaneously fortifying the security of the pool and $HTX applications. Founded on January 18, 2024, HTX DAO has enlisted 19 major builders to its ecosystem, including HTX, TRON, Poloniex, BitTorrent, Spark Digital Capital, APENFT, Stratified Capital, JustLend DAO, OIG Group, Double Peak, stUSDT, Zebec, USDD, ANKR, SUN.io, Merkle 3s Capital, WINkLink, TUSD, and Owlit Finance. These major builders are all prominent figures from various sectors within the blockchain industry. HTX DAO upholds exceptionally high standards in terms of transparency and community participation. Looking ahead, it fosters a diverse and dynamic landscape where contributors, innovators, and stakeholders collectively shape the trajectory of blockchain evolution. About HTX DAO As a multi-chain deployed decentralized autonomous organization (DAO), HTX DAO demonstrates an innovative governance approach. Unlike traditional corporate structures, it adopts a decentralized governance structure composed of a diversified group, jointly committed to the success of this organization. This unique ecosystem advocates openness and encourages all DAO participants to propose ideas that can promote the development of HTX DAO. Contact Information Website: www.htxdao.com About HTX DAO As a multi-chain deployed decentralized autonomous organization (DAO), HTX DAO demonstrates an innovative governance approach. Unlike traditional corporate structures, it adopts a decentralized governance structure composed of a diversified group, jointly committed to the success of this organization. This unique ecosystem advocates open values and encourages all DAO participants to propose collaborations and protocol enhancements that can promote the development of HTX DAO. Contact Details HTX DAO media@htxdao.com

July 17, 2024 12:03 PM Eastern Daylight Time

News Release

4 Standout Precious Metals Mining Stocks

FNM, AEM, LUN, RUP

Investor interest in mining stocks is rising as gold mining companies catch up with the precious metal’s value. Stabilizing mining costs and record-high gold prices have created a ripe environment for these stocks. Anticipation of a Federal Reserve rate cut, fueled by lower-than-expected inflation data, could boost both gold and mining stocks. With global demand for gold and other precious metals steadfast due to their historical allure and status as a safe haven, now could be a prime time to consider investing in solid gold and other precious metal mining stocks. Here are four picks that stand out in the current market. First Nordic Metals Corp. (TSXV: FNM) (OTC: FNMCF) stands out in the junior mining sector with its promising portfolio, particularly the Barsele gold project in Sweden. The company, in a joint venture with Agnico Eagle Mines Limited (TSX: AEM) (NYSE: AEM), has a robust foundation with an NI 43-101 indicated resource of 324,000 ounces of gold and an inferred resource of 2.1 million ounces. This significant resource, coupled with the project’s strategic location on the prolific Gold Line and Skellefte VMS belts, showcases the project's substantial growth potential. The ongoing 2024 diamond drilling program at Barsele marks a crucial phase in First Nordic's exploration activities. This 2,100-meter program aims to test high-potential targets identified through systematic geochemical surveys and geophysical data interpretation. The initial focus includes a shallow conductor target generated by the Titan-24 geophysical survey and follow-up drilling on the Risberget West structural trend. These efforts could expand the main resource area and uncover new mineralization zones, enhancing the project's value. FNM 's broader land holdings, including the 100,000 hectares surrounding Barsele and the underexplored Oijärvi Greenstone Belt in Finland, further amplify its exploration upside. The company's recent discovery of a 5-kilometer gold anomaly at the Storjuktan project is a testament to its exploration acumen. This anomaly, identified through a belt-scale glacial-to-geochemical survey, mirrors the scale of other multimillion-ounce deposits in the region. Financially, FNM is well-positioned, having recently raised $2.7 million through warrant and option exercises. This capital boost strengthens the company's cash position and supports its aggressive exploration and development plans. On July 15, 2024, First Nordic Metals Corp. announced significant progress in their ongoing diamond drilling program at the Barsele gold project. The latest drilling results have identified high-grade gold mineralization in several new zones, which were not previously included in the resource estimate. This discovery has the potential to substantially increase the project's overall resource base. The company reported the successful completion of the initial phase of the UAV magnetic survey over the Storjuktan project. Preliminary data indicates the presence of several high-priority targets, which will be further evaluated through ground-based geophysical methods and follow-up drilling. First Nordic Metals Corp. announced that it has entered into an agreement to finalize the acquisition of the Oijärvi Gold Project in Finland, which includes the resource-stage Kylmäkangas gold deposit—a drill-ready, high-grade gold project with significant resource expansion and district-scale growth potential. Additionally, Agnico Eagle Mines Limited (TSX: AEM) (NYSE: AEM) will become a 13.3% shareholder of FNM as part of this acquisition. Taj Singh, President and CEO of FNM, commented, "Oijärvi has all the key attributes FNM looks for in a high-quality project—high grades, significant growth potential, and a great location. Finalizing the acquisition of Oijärvi is yet another step towards our vision of becoming a leading gold development company. We are thrilled to welcome Agnico Eagle and look forward to having them as a significant shareholder." First Nordic Metals Corp. (TSXV: FNM) (OTC: FNMCF) offers a compelling investment opportunity in the junior mining space. With its flagship Barsele project, extensive land holdings, and a strong financial position, the company is well-equipped to unlock significant value and achieve substantial growth in the coming years. Investors looking for a promising gold exploration company with a solid foundation and exciting prospects should keep an eye on First Nordic Metals Corp. Agnico Eagle Mines Limited (TSX: AEM) (NYSE: AEM) is a Canadian-based senior gold mining company and the third largest gold producer globally, operating in Canada, Australia, Finland, and Mexico. Established in 1957, Agnico Eagle has a robust portfolio of high-quality exploration and development projects, as well as a consistent record of shareholder value through annual cash dividends since 1983. The company is set to release its Q2 2024 earnings on July 31, 2024, with projections indicating earnings of $0.81 per share, a 24.62% increase year-over-year, and revenue of $1.72 billion, a slight 0.05% rise from the same quarter last year. For the full year, analysts expect earnings of $3.16 per share and revenue of $7.48 billion, marking increases of 41.7% and 12.88%, respectively. In Q1 2024, Agnico Eagle reported strong results, including record operating margins and free cash flow. The company produced 878,652 ounces of gold at a total cash cost of $901 per ounce and an all-in sustaining cost of $1,190 per ounce. Net income for the quarter was $347.2 million, or $0.70 per share, with adjusted net income of $377.5 million, or $0.76 per share. Agnico Eagle continues to demonstrate its commitment to environmental, social, and governance (ESG) practices, achieving its best safety performance in 2023 and advancing its climate resilience goals. The company maintains a strong balance sheet, increasing its cash position by $186 million and reducing its net debt in Q1 2024. The company's stock has performed well, surging 36.1% over the past six months, with some analysts projecting a near-term target of $78.69, indicating a potential upside of 12.09%. Lundin Mining (TSX: LUN) is a diversified Canadian base metals mining company with a robust presence in Argentina, Brazil, Chile, Portugal, Sweden, and the United States. It primarily produces copper, zinc, gold, and nickel, making it a significant player in the global mining sector. Recently, the company made a strategic move to strengthen its copper production profile by increasing its stake in the Caserones copper-molybdenum mine in Chile. On July 2, 2024, LUN closed the option to acquire an additional 19% interest in SCM Minera Lumina Copper Chile, the owner of Caserones, from JX Advanced Metals Corporation. This $350 million cash transaction elevated Lundin's ownership to 70%, adding approximately 120,000-130,000 tons of copper to its production capacity annually. This acquisition not only enhances Lundin’s copper output but also solidifies its position in a tier-one mining jurisdiction within the Vicuña District, a region known for its rich mineral deposits. LUN is committed to growth and operational efficiency. The company is focused on optimizing its assets and reducing costs, which is evident from its robust exploration efforts. With a $48-million exploration budget for 2024, Lundin is conducting extensive drilling campaigns at Caserones, Josemaria, Chapada, and Zinkgruvan, targeting high-potential areas and extensions to existing deposits. These efforts are expected to uncover significant resources that could further bolster the company’s production capabilities. The market has responded positively to Lundin’s strategic initiatives, with its shares gaining 45.7% in the past six months. The Zacks Consensus Estimate for Lundin’s fiscal 2024 earnings suggests a remarkable year-over-year improvement of 91%, with the consensus estimate having risen by 42% in the past 90 days. Adding to its growth potential, Lundin Mining is reportedly in discussions with BHP Group for a possible joint bid for Filo Corp. This move could address the fundraising needs for Lundin’s neighboring Josemaria project and potentially lead to significant cost synergies through shared infrastructure between the two projects. Such strategic collaborations highlight Lundin’s proactive approach to expansion and resource optimization. Rupert Resources (TSX: RUP) is an emerging gold exploration and development company primarily focused on the Ikkari gold discovery within the Rupert Lapland Project in Northern Finland, which also includes the Pahtavaara gold mine and mill. Rupert aims to advance high-margin, environmentally responsible discoveries, positioning itself as a significant player in the gold mining sector. The Ikkari project is noted for its exceptional resource continuity and high-grade recoveries through conventional processing routes. Located near excellent infrastructure and renewable power sources, Ikkari is a standout asset in RUP’s portfolio. The company is working on the Preliminary Feasibility Study (PFS) and the Environmental Impact Statement (EIA) for Ikkari, with plans to publish the PFS later in 2024. This approach reflects Rupert’s commitment to optimal project development and disciplined investment. Financially, RUP is strong, reporting cash or cash equivalents of approximately C$27 million as of May 31, 2024, despite spending over C$11 million on exploration in the previous quarter. This financial health supports ongoing and future initiatives, even amid challenges such as the inability to consolidate additional exploration licenses near Ikkari through the Fingold JV. Operationally, RUP on the Ikkari deposit and the broader Rupert Lapland Project Area. The regional exploration program aims to evaluate the mineral potential within Rupert’s land package. Since July 2020, an extensive diamond drilling program has generated new targets through base of till (BoT) sampling. Significant progress has been made, with a Preliminary Economic Assessment (PEA) and a Mineral Resource (MR) completed. Over 42,000 meters of drilling have tested extensions of the Ikkari mineralization, providing data for the forthcoming Feasibility Study. Recent drilling at Heinä South has also shown promising results. Rupert Resources’ strategic focus on high-quality gold assets, strong financial position, and commitment to sustainability make it a compelling investment opportunity in the gold mining industry. Disclaimers: RazorPitch Inc. "RazorPitch" is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. RazorPitch has been retained and compensated by Cambridge Consulting to assist in the production and distribution of content related to FNM. RazorPitch is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Contact Details Mark McKelvie +1 585-301-7700 mark@razorpitch.com Company Website http://razorpitch.com

July 16, 2024 06:00 AM Eastern Daylight Time

Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer

Autonomix Medical, Inc.

By Austin DeNoce, Benzinga Autonomix Medical (NASDAQ: AMIX) is a cutting-edge medical technology company developing targeted nerve therapies to revolutionize how diseases involving the peripheral nervous system are diagnosed and treated. The company's ongoing proof-of-concept (PoC) human clinical trial is evaluating the safety and efficacy of radiofrequency (RF) ablation in a transvascular approach to reduce pain associated with pancreatic cancer and, to date, has demonstrated extremely compelling results. If successful, Autonomix has the potential to dramatically impact patient well-being and improve quality of life, offering new hope for patients enduring pancreatic cancer pain. Key Trial Insights The initial phase of the clinical trial involved five lead in patients who underwent the procedure without complications or significant adverse events. Some 60% of these subjects experienced a significant reduction in pain, with a mean decrease of 6.33 points on the Visual Analogue Scale (VAS) pain scale, dropping from a baseline of 8.0 to 1.67 just seven days post-procedure. Patients also reported quick pain relief, with some feeling better as soon as one day after the procedure. A detailed look at the data should provide Autonomix with important insight into optimizing the procedure, particularly the catheter entry point, where three of the five patients who benefited with meaningful pain reduction had femoral access to the catheter and the two that did not respond had brachial access. The primary objective of this PoC trial is to assess the success rate of ablating relevant nerves to mitigate pain in patients with pancreatic cancer using radiofrequency ablation. Secondary objectives include evaluating device- and procedure-related adverse events up to six weeks post-procedure, changes in pain levels and improvements in quality of life from pre- to post-procedure. Autonomix is proceeding with enrolling an additional 20 subjects to participate in the study and expects to complete enrollment by the end of 2024. The company expects to report topline results from all 20 subjects in the first half of next year. Clinical Trial Testimonials According to Autonomix, patients in the responder group reported substantial improvements in their quality of life. On average, these patients noted a 78% enhancement in how they viewed their overall health and a 45% boost in how they viewed their life quality, within seven days of the procedure. This rapid relief is crucial for individuals facing end-of-life situations due to advanced pancreatic cancer, offering them a better quality of life during their remaining time. Patient testimonial s further emphasize the impact of the procedure. Before the procedure, patients can struggle with debilitating pain, which affects their ability to sleep, eat and perform daily activities. Post-procedure, patients experienced immediate, life-changing pain relief and could sleep on their back, return to work and attend social events. Additionally, one patient stated they no longer needed painkillers, and experienced significant improvements in overall health and quality of life. This transformation underscores the procedure's potential to greatly enhance the lives of patients suffering from pancreatic cancer pain. Technical Approach And Future Plans Autonomix's technology aims to improve upon current pain management methods, which often rely on systemic drugs like opioids or invasive procedures that can have severe side effects. Autonomix’s catheter-based system is also designed to detect and ablate pain-associated neural signals more accurately. While the current trial focuses on pancreatic cancer-related pain, Autonomix also plans to explore other indications in the future based on these promising results. A New Dawn In Pain Management Autonomix’s innovative approach to pain management for pancreatic cancer patients is showing encouraging potential. The initial success of its PoC clinical trial offers a glimpse into a possible future where patients suffering from severe pain can find relief through precise and effective medical technology. As the company gathers more data, the medical community awaits its results, which could revolutionize pain management far beyond just pancreatic cancer pain and have applications across all pain and diseases of the peripheral nervous system. Featured photo by Alexander Grey on Unsplash Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate neural signals with approximately 3,000 times greater sensitivity than currently available technologies. We believe this will enable, for the first time ever, transvascular diagnosis and treatment of diseases involving the peripheral nervous system virtually anywhere in the body.We are initially developing our technology for pancreatic cancer pain, a condition that can cause debilitating pain and needs an effective solution. However, our technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation and chronic pain management across a wide disease spectrum. Some of the statements in this release are “forward-looking statements,” which involve risks and uncertainties. Forward-looking statements in this press release include, without limitation, the timing of the completion of patient enrollment in the trial and the Company’s ability to successfully meet the milestones set forth in this press release on a timely basis, if at all. Such forward-looking statements can be identified by the use of words such as ‘should,’ ‘may,’ ‘intends,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘forecasts,’ ‘expects,’ ‘plans,’ and ‘proposes.’Although Autonomix Medical, Inc. (or Autonomix) believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere in the offering circular filed with the U.S. Securities and Exchange Commission (“SEC”) on January 26, 2024. Forward-looking statements speak only as of the date of the document in which they are contained and Autonomix does not undertake any duty to update any forward-looking statements except as may be required by law. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details JTC Team, LLC autonomix@jtcir.com Company Website https://autonomix.com/

July 12, 2024 08:45 AM Eastern Daylight Time

Image

peran+perawat+dalam+pencegahan+gagal+ventilasi+pada+pasien+covid+19

Quantitative Easing Could Occur Soon – Here's What That Could Mean For Crypto, And How To Benefit

KindlyMD, Inc. (NASDAQ: KDLY): Advancing the $11.6 Billion Medical Cannabis Market in Chronic Pain Treatment

Playing Your Hand Wisely: Navigating Futures Trading With Precision And Planning

BDA Announces 2025 Bermuda Risk Summit Dates

Perú introdujo diez nuevas rutas para acceder al Santuario Histórico de Machupicchu

Forum Health Breaks into Denver Market with Acquisition of Concierge Functional and Regenerative Medicine Practice

Total Liquidity Pledge to HTX DAO Hits $42.5M After 2nd Round - Bolstering Decentralized Ecosystem

4 Standout Precious Metals Mining Stocks

Autonomix's Trial Results Show Meaningful Reduction In Pain For Patients Suffering From Pancreatic Cancer